GlassScriptPhysician profile
William Theodore Simpson
NPI 1144879628
$7,158.16
in general payments reported to CMS, 2019-2025
44 companies · $1,067 in 2025
The $1,067 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $796 · 2022: $2,344 · 2023: $1,639 · 2024: $1,313 · 2025: $1,067.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,904 · Education: $115.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,903.74 |
| Education | $115.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,499.24 | 2021-2025 | |
| Astellas Pharma US INC | $560.65 | 2021-2024 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $497.52 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $463.82 | 2021-2025 | Provenge |
| Abbvie INC. | $418.47 | 2021-2025 | |
| Tolmar, INC. | $358.38 | 2023-2025 | Eligard, Jatenzo |
| Merck Sharp & Dohme LLC | $350.03 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $291.89 | 2022-2025 | |
| Teleflex LLC | $208.53 | 2021-2025 | Barrigel |
| Myriad Genetic Laboratories, INC. | $185.09 | 2021-2025 | Prolaris |
| Myovant Sciences INC. | $181.00 | 2021-2022 | |
| Convatec INC. | $169.64 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $165.39 | 2022-2025 | |
| Antares Pharma, INC. | $147.55 | 2021-2023 | Tlando, Xyosted, Nocdurna |
| Astrazeneca Pharmaceuticals LP | $130.39 | 2024-2025 | Lynparza |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $125.96 | 2021-2024 | Cure Catheter |
| Travere Therapeutics, INC. | $117.79 | 2021-2022 | |
| Janssen Biotech, INC. | $96.34 | 2023-2025 | Erleada |
| Amgen INC. | $96.22 | 2021-2023 | Xgeva |
| Progenics Pharmaceuticals, INC. | $94.98 | 2023-2025 | Pylarify |
| Urogen Pharma, INC. | $88.53 | 2022-2025 | |
| Telix Pharmaceuticals | $79.53 | 2023-2025 | Illuccix |
| Laborie Medical Technologies Corp. | $73.24 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Boston Scientific Corporation | $70.95 | 2023-2024 | Rezum Generator, Greenlight Xps |
| Ferring Pharmaceuticals INC. | $70.39 | 2025 | Adstiladrin |
| Olympus America INC. | $66.05 | 2025 | Itind System |
| Endo Pharmaceuticals INC. | $64.32 | 2021-2023 | Xiaflex, Aveed |
| Blue Earth Diagnostics | $51.51 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $50.28 | 2022-2023 | Yonsa |
| Angiodynamics, INC. | $48.34 | 2021 | |
| Novartis Pharmaceuticals Corporation | $46.77 | 2022-2025 | |
| Endo USA, INC. | $44.64 | 2024 | Aveed, Xiaflex |
| Axonics, INC. | $34.80 | 2023 | Axonics, Bulkamid |
| Alnylam Pharmaceuticals INC. | $32.92 | 2021-2024 | Oxlumo |
| Lilly USA, LLC | $23.02 | 2023 | Trulicity, Mounjaro |
| Profound Medical Corp. | $22.94 | 2025 | Tulsa-Pro |
| Hollister Incorporated | $20.67 | 2023 | Vapro |
| Novo Nordisk INC | $19.38 | 2023 | Wegovy |
| Halozyme INC | $18.20 | 2023 | |
| Gilead Sciences, INC. | $17.40 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $15.82 | 2023 | Seglentis |
| Karl Storz Endoscopy-America | $14.47 | 2022 | |
| Ambu INC. | $13.48 | 2022 | |
| Smith+Nephew, INC. | $11.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.